Search

Search Constraints

You searched for: Author/Creator van Doorn, Helena C.

Search Results

1. A patient decision aid for risk‐reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing. (27th December 2017)

3. Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia. (November 2019)

4. Corrigendum to "The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer" [Breast 52 (2020) 102–109]. (October 2020)

5. Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?. Issue 8 (August 2016)

6. Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?. Issue 8 (August 2016)

7. Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies. (19th May 2018)

8. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status. Issue 1 (3rd September 2019)

10. Incidence and Survival Trends of Uncommon Corpus Uteri Malignancies in the Netherlands, 1989–2008. Issue 4 (1st May 2012)